CN108853433A - A kind of Chinese medicine and preparation method thereof for treating diabetic nephropathy - Google Patents
A kind of Chinese medicine and preparation method thereof for treating diabetic nephropathy Download PDFInfo
- Publication number
- CN108853433A CN108853433A CN201811009506.3A CN201811009506A CN108853433A CN 108853433 A CN108853433 A CN 108853433A CN 201811009506 A CN201811009506 A CN 201811009506A CN 108853433 A CN108853433 A CN 108853433A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- diabetic nephropathy
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 46
- 208000007342 Diabetic Nephropathies Diseases 0.000 title claims abstract description 27
- 208000033679 diabetic kidney disease Diseases 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 22
- 150000001875 compounds Chemical class 0.000 claims abstract description 15
- 239000009636 Huang Qi Substances 0.000 claims abstract description 14
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 12
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 12
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims abstract description 12
- 241000756943 Codonopsis Species 0.000 claims abstract description 12
- 244000163122 Curcuma domestica Species 0.000 claims abstract description 12
- 235000003392 Curcuma domestica Nutrition 0.000 claims abstract description 12
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 12
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 12
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 12
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 12
- 241000132521 Erigeron Species 0.000 claims abstract description 12
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 claims abstract description 12
- 241000545744 Hirudinea Species 0.000 claims abstract description 12
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 claims abstract description 12
- 241000830535 Ligustrum lucidum Species 0.000 claims abstract description 12
- 241000237636 Pheretima Species 0.000 claims abstract description 12
- 235000008081 Rheum officinale Nutrition 0.000 claims abstract description 12
- 240000004980 Rheum officinale Species 0.000 claims abstract description 12
- 241001165494 Rhodiola Species 0.000 claims abstract description 12
- 240000008042 Zea mays Species 0.000 claims abstract description 12
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 12
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 12
- 235000005822 corn Nutrition 0.000 claims abstract description 12
- 235000003373 curcuma longa Nutrition 0.000 claims abstract description 12
- 210000000582 semen Anatomy 0.000 claims abstract description 12
- 235000013976 turmeric Nutrition 0.000 claims abstract description 12
- 240000006509 Gynostemma pentaphyllum Species 0.000 claims abstract description 11
- 244000197580 Poria cocos Species 0.000 claims abstract description 11
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 11
- 241000830536 Tripterygium wilfordii Species 0.000 claims abstract description 11
- 235000015398 thunder god vine Nutrition 0.000 claims abstract description 11
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 10
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 10
- 235000000661 Rosa laevigata Nutrition 0.000 claims abstract description 10
- 241001278833 Rosa laevigata Species 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 239000000126 substance Substances 0.000 claims abstract description 6
- 239000000284 extract Substances 0.000 claims description 16
- 239000000706 filtrate Substances 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 8
- 229940126062 Compound A Drugs 0.000 claims description 7
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 claims description 7
- 239000002775 capsule Substances 0.000 claims description 6
- 235000019441 ethanol Nutrition 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 239000000047 product Substances 0.000 claims description 3
- 239000002893 slag Substances 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000007598 dipping method Methods 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 240000007890 Leonurus cardiaca Species 0.000 claims 3
- 241001251949 Xanthium sibiricum Species 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 10
- 201000010099 disease Diseases 0.000 abstract description 9
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 239000013256 coordination polymer Substances 0.000 abstract description 2
- 230000002218 hypoglycaemic effect Effects 0.000 abstract description 2
- 230000002265 prevention Effects 0.000 abstract description 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 2
- 244000192528 Chrysanthemum parthenium Species 0.000 abstract 1
- 210000002700 urine Anatomy 0.000 description 23
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 22
- 102000004169 proteins and genes Human genes 0.000 description 22
- 108090000623 proteins and genes Proteins 0.000 description 22
- 210000004369 blood Anatomy 0.000 description 21
- 239000008280 blood Substances 0.000 description 20
- 239000008103 glucose Substances 0.000 description 19
- 229940079593 drug Drugs 0.000 description 14
- 229940109239 creatinine Drugs 0.000 description 11
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 10
- 206010012601 diabetes mellitus Diseases 0.000 description 10
- 241000207925 Leonurus Species 0.000 description 8
- 241000700159 Rattus Species 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 5
- 206010029164 Nephrotic syndrome Diseases 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 208000009928 nephrosis Diseases 0.000 description 4
- 231100001027 nephrosis Toxicity 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 102000015779 HDL Lipoproteins Human genes 0.000 description 2
- 108010010234 HDL Lipoproteins Proteins 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000007373 indentation Methods 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000221079 Euphorbia <genus> Species 0.000 description 1
- 206010018473 Glycosuria Diseases 0.000 description 1
- 241001065361 Gynostemma Species 0.000 description 1
- 206010030124 Oedema peripheral Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical group N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 235000021270 cold food Nutrition 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 208000028208 end stage renal disease Diseases 0.000 description 1
- 201000000523 end stage renal failure Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- WIGIZIANZCJQQY-RUCARUNLSA-N glimepiride Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)N[C@@H]2CC[C@@H](C)CC2)C=C1 WIGIZIANZCJQQY-RUCARUNLSA-N 0.000 description 1
- 229960004346 glimepiride Drugs 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- -1 prepares simply Substances 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 230000003393 splenic effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 1
- 229960001052 streptozocin Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229940126672 traditional medicines Drugs 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/37—Celastraceae (Staff-tree or Bittersweet family), e.g. tripterygium or spindletree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/424—Gynostemma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/43—Cuscutaceae (Dodder family), e.g. Cuscuta epithymum or greater dodder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/638—Ligustrum, e.g. Chinese privet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to technical field of traditional Chinese medicines, particularly disclose a kind of Chinese medicine and preparation method thereof for treating diabetic nephropathy.The Chinese medicine of the treatment diabetic nephropathy, using Radix Astragali, Radix Angelicae Sinensis, Chinese yam, Radix Salviae Miltiorrhizae, Radix Codonopsis, radix paeoniae rubra, motherwort, the fruit of Cherokee rose, radix rehmanniae recen, Fructus Corni, the fruit of glossy privet, safflower, Rhizoma Chuanxiong, Semen Cuscutae, radix achyranthis bidentatae, leech, pheretima, Radix Notoginseng, rheum officinale, Poria cocos, rhizoma alismatis, fleabane flower, gynostemma pentaphylla, tripterygium wilfordii, corn stigma, Herba Euphorbiae Humifusae, turmeric and root of kirilow rhodiola as raw material, it is mixed according to certain parts by weight.The present invention is made of pure Chinese medicine, the compound CP method relevant regulations of each component, using the compatibility effect of each taste Chinese medicine, is free of chemical components, hormone-free, has no toxic side effect, and treating both manifestation and root cause of disease has the function that preferably hypoglycemic and prevention and treatment diabetic nephropathy.
Description
(One)Technical field
The present invention relates to technical field of traditional Chinese medicines, in particular to a kind of Chinese medicine and preparation method thereof for treating diabetes mind soldier.
(Two)Background technique
The disease incidence of diabetes just increases year by year, and nearly 10 years diabetes popularities are even more serious.Diabetes B(T2DM)Account for sugar
The 90% of the total case of urine disease, it has also become seriously affect one of the disease of mankind nowadays health.Nowadays diabetes mellitus in China patient occupies
First place in the world.China has 1,300,000 people to die of diabetes and its complication within 2015, wherein 40.8% man-year age is lower than 60 years old, by
Rejuvenation trend is gradually presented.T2DM vascular complication be mainly disable, the cause of death.Wherein, diabetic nephropathy(Diabetic
Nephropathy, DN)It is one of the major chronic microvascular complication of diabetes, and leads to End-stage renal failure
Major reason.
The significant damage brought by the diabetes and its complication, doctors attempt various treatment methods to treat and subtract
Slow conditions of patients and pain.Motherland's medicine thinks the disease categories such as diabetic nephropathy ownership " quenching one's thirst ", " oedema ", basic pathogenesis
For " asthenia in origin and asthenia in superficiality ".This void refers to the deficient of the five internal organs negative and positive of qi and blood, and real mark is that blood stasis hinders network.《The big opinion of Plain Questions YIN YANG classification of natural phenomena》Speech:
" treatment of disease must aim at its pathogenesis ", the embodiment for being organic conception and diagnosis and treatment in treatment is seen of searching for the primary cause of disease in treatment, is the master of traditional Chinese medicine treatment
Lead thought.The diabetic nephropathy interpretation of the cause, onset and process of an illness is qi deficiency to blood stasis, therefore treatment should take into account " deficiency of vital energy " and " blood stasis "." QI invigorating ", the first prosperous energy of gas
Green blood, second gas row then blood, for the method effected a permanent cure;" promoting blood circulation " then the stasis of blood must be logical except blood vessels, and new blood must be raw, for the method for temporary solution.Therefore its
Treating big method is qi and activate blood circulation.
(Three)Summary of the invention
In order to compensate for the shortcomings of the prior art, the present invention provides a kind of simple processes, low in cost, effective treatment sugar
Urinate the Chinese medicine and preparation method thereof of sick nephrosis.
The present invention is achieved through the following technical solutions:
A kind of Chinese medicine for treating diabetic nephropathy, it is characterized in that, it is mixed by the raw material of following parts by weight:Radix Astragali 20-40
Part, 15-25 parts of Radix Angelicae Sinensis, 10-20 parts of Chinese yam, 20-40 parts of Radix Salviae Miltiorrhizae, 10-20 parts of Radix Codonopsis, 10-20 parts of radix paeoniae rubra, 10-20 parts of motherwort,
20-40 parts of the fruit of Cherokee rose, 10-20 parts of radix rehmanniae recen, 8-12 parts of Fructus Corni, 10-20 parts of the fruit of glossy privet, 9-15 parts of safflower, Rhizoma Chuanxiong 10-20
Part, 10-20 parts of Semen Cuscutae, 10-20 parts of radix achyranthis bidentatae, 9-15 parts of leech, 9-15 parts of pheretima, 2-4 parts of Radix Notoginseng, 6-12 parts of rheum officinale, Poria cocos
10-20 parts, 20-40 parts of rhizoma alismatis, 20-40 parts of fleabane flower, 20-40 parts of gynostemma pentaphylla, 10-20 parts of tripterygium wilfordii, 20-40 parts of corn stigma,
10-20 parts of Herba Euphorbiae Humifusae, 10-20 parts of turmeric, 20-40 parts of root of kirilow rhodiola.
Its preferred weight proportion is:
30 parts of Radix Astragali, 20 parts of Radix Angelicae Sinensis, 15 parts of Chinese yam, 30 parts of Radix Salviae Miltiorrhizae, 15 parts of Radix Codonopsis, 15 parts of radix paeoniae rubra, 15 parts of motherwort, the fruit of Cherokee rose 30
Part, 15 parts of radix rehmanniae recen, 10 parts of Fructus Corni, 15 parts of the fruit of glossy privet, 12 parts of safflower, 15 parts of Rhizoma Chuanxiong, 15 parts of Semen Cuscutae, 15 parts of radix achyranthis bidentatae, water
12 parts of leech, 12 parts of pheretima, 3 parts of Radix Notoginseng, 9 parts of rheum officinale, 15 parts of Poria cocos, 30 parts of rhizoma alismatis, 30 parts of fleabane flower, 30 parts of gynostemma pentaphylla, Thunder God
15 parts of rattan, 30 parts of corn stigma, 15 parts of Herba Euphorbiae Humifusae, 15 parts of turmeric, 30 parts of root of kirilow rhodiola.
Chinese medicine of the present invention is capsule.The mode of taking be it is oral, three times per day, half an hour takes before meals, every time
0.5g, a month as a treatment course.
The present invention combines dialectical argumentation by the research to traditional Chinese medicine, and the multi-party length for collecting many families seeks most preferably to control
Treatment scheme is matched through system research, scientific compatibility using Radix Astragali, Radix Angelicae Sinensis by theory of traditional Chinese medical science prescription using natural Chinese traditional medicines raw material
5 other drugs treat diabetic nephropathy caused by qi deficiency to blood stasis patients with type Ⅰ DM, significant effect;In conjunction with Traditional Chinese Medicine technology
It is configured to Chinese medicine of the invention meticulously, there is preferable effect to diabetic nephropathy.
The present invention treats the preparation method of the Chinese medicine of diabetic nephropathy, includes the following steps:
(1)Each bulk pharmaceutical chemicals are weighed respectively, it is spare;
(2)Take Chinese yam, Radix Salviae Miltiorrhizae, Radix Codonopsis, radix paeoniae rubra, the fruit of Cherokee rose, safflower, Semen Cuscutae, leech, Poria cocos, fleabane flower, Herba Euphorbiae Humifusae mixing equal
It is even, it adds water to cook twice, is collected by filtration after filtrate and merges filtrate twice, be condensed into medicinal extract after cooling, then dries pulverizing is at powder,
Obtain compound A;
(3)Take Radix Astragali, Radix Angelicae Sinensis, motherwort, radix rehmanniae recen, Fructus Corni, the fruit of glossy privet, Rhizoma Chuanxiong, radix achyranthis bidentatae, pheretima, Radix Notoginseng, rheum officinale, rhizoma alismatis,
Gynostemma pentaphylla, tripterygium wilfordii, corn stigma, turmeric, root of kirilow rhodiola add ethyl alcohol to impregnate, and extract twice, combined extract filters, is condensed into leaching
Cream, crushed after being dried obtain compound B;
(4)Compound A and compound B are uniformly mixed, capsule product is made in sterilization.
More excellent technical solution of the invention is:
Step(2)In, twice in decoction, for the first time plus the water of three times weight is boiled by intense fire, is then cooked by slow fire 1 hour, is filtered
Collect filtrate and filter residue;Into filter residue plus water regards no filter slag as criterion, and boils by intense fire, is then cooked by slow fire 30 minutes, and filtering is received
Collect filtrate.
Step(2)With(3)In, the density of medicinal extract is that 1.1-1.2g/mL is ground into powder, obtains compound after drying at 80 DEG C
Object A.
Step(3)In, adding mass concentration is alcohol solution dipping 0.5-1.5 hours of 70%, is extracted twice, each 1-2 is small
When, combined extract;The relative density of medicinal extract is 1.2 after concentration.
In drug of the invention, the sweet temperature rise hair of Radix Astragali, function arrogates to oneself tonifying Qi, is " length of tonic ";Energy help three is burnt, internal organs in table
All gas;Radix Angelicae Sinensis acrid flavour, hardship, sweet, tepor, have effects that inrigorating qi and promoting blood circulation, menstruction regulating and pain relieving;There are the discussion of Radix Angelicae Sinensis in successive dynasties' successive dynasties
Very much, such as《Haigoushen》In mention the power that Radix Angelicae Sinensis has " broken place blood ";Radix Codonopsis, Chinese yam, Fructus Corni etc. have tonifying middle-Jiao and Qi, stop
Yearningly, the effect of strengthening the spleen and replenishing qi, nourishes blood and promotes the production of body fluid, the function of Radix Astragali tonifying Qi is helped;Radix Salviae Miltiorrhizae, radix paeoniae rubra, safflower, leech, pheretima, Radix Notoginseng, humid euphorbia
It is the blood-breakings such as grass, very strong by the stasis of blood, the power of promoting menstruation, Radix Angelicae Sinensis promoting blood circulation, Po Disorder dissipating bind is helped, turmeric, fleabane flower, gynostemma pentaphylla dissipate the stasis of blood and stop
Bitterly, promoting blood circulation and removing obstruction in channels;Root of kirilow rhodiola qi and activate blood circulation is removed obstruction in channels to relieve pain;Corn stigma inducing diuresis for removing edema, rheum officinale, rhizoma alismatis let out turbid;Poria cocos invigorating the spleen;Ox
The yin that knee, tripterygium wilfordii, motherwort, the fruit of glossy privet, Semen Cuscutae are tonified the liver and kidney.The benefits of inrigorating qi and promoting blood circulation is played altogether by full side, and it is strong to take into account benefiting yin
It is the splenic diarrhea turbid and other effects.
Every medicinal material in prescription is carried out compatibility using conventional method by Chinese medicine of the invention in proportion, by existing preparation work
Various clinical applicable dosage forms are made in skill, and every medicinal material used is commercially available by examining qualified Chinese medicine.
Raw medicinal material army of the present invention uses natural Chinese medicine material, prepares simply, and medicine source is extensive, low in cost, abides by
The prescriptions principle of Chinese medicine is followed, all medicines share brings out the best in each other, and preparation dose is small, and effective ingredient is easy to discharge, and inhales
It receives fastly, bioavilability is high, so that drug effect is sufficiently volatilized, verifies by clinic application, significant in efficacy reliable, medicinal peace,
Do not occur toxic side effect, has a extensive future.
Avoided pungent and cold food for duration of medication, avoids emotional stimulation, quits smoking and gives up alcohol, and life wants regular, appropriate to forge
Refining.
The present invention is made of pure Chinese medicine, the compound CP method relevant regulations of each component, using the compatibility effect of each taste Chinese medicine, no
It is hormone-free containing chemical components, it has no toxic side effect, treating both manifestation and root cause of disease reaches preferably hypoglycemic and prevention and treatment diabetogenous nephrosis
The effect of disease, total effective rate is high, and simple process reduces production cost, alleviates the financial burden of patient.
(Four)Specific embodiment
Carry out the explained in details present invention below by specific embodiment, but is not intended as the limitation to the content of present invention.
Embodiment 1:
A kind of Chinese herbal compounds for treating diabetic nephropathy, are prepared by following raw materials
Radix Astragali 30g, Radix Angelicae Sinensis 20g, Chinese yam 15g, Radix Salviae Miltiorrhizae 30g, Radix Codonopsis 15g, radix paeoniae rubra 15g, motherwort 15g, fruit of Cherokee rose 30g, Radix Rehmanniae
15g, Fructus Corni 10g, fruit of glossy privet 15g, safflower 12g, Rhizoma Chuanxiong 15g, Semen Cuscutae 15g, radix achyranthis bidentatae 15g, leech 12g, pheretima 12g, three
Seven powder 3g, rheum officinale 9g, Poria cocos 15g, rhizoma alismatis 30g, fleabane flower 30g, gynostemma pentaphylla 30g, tripterygium wilfordii 15g, corn stigma 30g, Herba Euphorbiae Humifusae
15g, turmeric 15g, root of kirilow rhodiola 30g.
The preparation method of the Chinese herbal compounds of above-mentioned treatment diabetic nephropathy is:Take the bulk pharmaceutical chemicals (proportion of above-mentioned parts by weight
Unit:Gram) capsule is prepared, concrete operations are:
(1)Each bulk pharmaceutical chemicals are weighed, it is spare;
(2)Take Radix Codonopsis, Chinese yam, Radix Salviae Miltiorrhizae, radix paeoniae rubra, the fruit of Cherokee rose, safflower, Semen Cuscutae, leech, Poria cocos, fleabane flower, Herba Euphorbiae Humifusae mixing equal
It is even, add the water of 3 times of weight to boil by intense fire, is then cooked by slow fire 1 hour, filtrate and filter residue is collected by filtration;Water is added into filter residue,
It regards no filter slag as criterion, boils by intense fire, be then cooked by slow fire 30 minutes, filtrate is collected by filtration;Merge above-mentioned filtrate twice, it is cooling
Afterwards, it is condensed into the medicinal extract that density is 1.1-1.2g/ml;After 80 DEG C of drying, it is ground into powder, as compound A;
(3)Take Radix Astragali, Radix Angelicae Sinensis, motherwort, radix rehmanniae recen, Fructus Corni, the fruit of glossy privet, Rhizoma Chuanxiong, radix achyranthis bidentatae, pheretima, Radix Notoginseng powder, rheum officinale, pool
Rush down, gynostemma pentaphylla, tripterygium wilfordii, corn stigma, turmeric, root of kirilow rhodiola add 70% ethyl alcohol to impregnate 0.5-1.5 hour, extraction twice, each 1-
2 hours, combined extract, filtration was condensed into the medicinal extract that relative density is 1.2, and crushed after being dried obtains compound B;
(4)Compound A and compound B are mixed evenly, capsule product is made in sterilization.
Take mode:Oral, three times per day, half an hour takes before meals, each 0.5g, a month as a treatment course.
Embodiment 2:
A kind of Chinese herbal compounds for treating diabetic nephropathy, are prepared by following raw materials,
Radix Astragali 50g, Radix Angelicae Sinensis 35g, Chinese yam 25g, Radix Salviae Miltiorrhizae 50g, Radix Codonopsis 25g, radix paeoniae rubra 25g, motherwort 25g, fruit of Cherokee rose 50g, Radix Rehmanniae
25g, Fructus Corni 15g, fruit of glossy privet 25g, safflower 20g, Rhizoma Chuanxiong 25g, Semen Cuscutae 25g, radix achyranthis bidentatae 25g, leech 20g, pheretima 20g, three
Seven powder 5g, rheum officinale 15g, Poria cocos 25g, rhizoma alismatis 50g, fleabane flower 50g, gynostemma pentaphylla 50g, tripterygium wilfordii 25g, corn stigma 50g, Herba Euphorbiae Humifusae
25g, turmeric 25g, root of kirilow rhodiola 50g.
Preparation and instructions of taking such as embodiment 1.
Embodiment 3:
A kind of Chinese herbal compounds for treating diabetic nephropathy, are prepared by following raw materials,
Radix Astragali 40g, Radix Angelicae Sinensis 25g, Chinese yam 20, Radix Salviae Miltiorrhizae 40g, Radix Codonopsis 20g, radix paeoniae rubra 20g, motherwort 20g, fruit of Cherokee rose 40g, Radix Rehmanniae
20g, Fructus Corni 12g, fruit of glossy privet 20g, safflower 16g, Rhizoma Chuanxiong 20, Semen Cuscutae 20g, radix achyranthis bidentatae 20g, leech 16g, pheretima 16g, Radix Notoginseng
Powder 4g, rheum officinale 12g, Poria cocos 20g, rhizoma alismatis 40g, fleabane flower 40g, gynostemma pentaphylla 40g, tripterygium wilfordii 20g, corn stigma 40g, Herba Euphorbiae Humifusae
20g, turmeric 20g, root of kirilow rhodiola 40g.
Preparation and instructions of taking such as embodiment 1.
Embodiment 4:Experiment of Zoology
Experiment process:
SPF grades of 8 week old Wistar Adult male rats 90 are selected at random, are provided by Shandong Traditional Chinese Medicine University's Animal Lab., body
Weigh 200 ± 20g, ad lib and drinking-water, the control of animal house temperature is at 22-26 DEG C of temperature, humidity 55%, illumination 12/24h.It adapts to
Property raising 1 week, blood glucose is to measure weight in normal range (NR), detection fasting blood-glucose(FBG), triglycerides(TG), total cholesterol
(TC), low-density lipoprotein(LDL), high-density lipoprotein(HDL), Urine proteins creatinine ratio, for 24 hours quantify Urine proteins.
It is randomly divided into blank group(n=10)And modeling group(n=80).The excision of modeling group rat advance Rats With Unilateral kidney,
Method:10% chloraldurate 3.5mL/kg intraperitoneal injection of anesthesia, routine disinfection, midline incision 1-1.5mm, the left kidney of exposure remove rouge
Fat and adrenal gland ligature blood vessel, cut off left kidney, sew up the incision, and postoperative rat injects 400,000 units of Penicillin and prevents from infecting, continuously
Three days.Give streptozotocin within postoperative 1 week(The sodium citrate buffer solution of pH=4.4 0.1mol/L is dissolved in 0 DEG C, need to be ready-to-use,
Final concentration of 10mg/mL is injected by 40mg/kg disposable celiac).Modeling group gives high glucose and high fat feed 8 weeks, and blank group excision is left
Kidney simultaneously injects isodose buffer, gives standard rat chow 8 weeks.72 hours tail vein bloods before use after 8 weeks, continuously three times
Random blood sugar >=16.7mmol/L and Urine proteins creatinine ratio >=25mg/mmol, Urine proteins >=150mg person is quantified for 24 hours be determined as
Diabetic nephropathy model rat.
The successful rat of modeling 60 is taken, is randomly divided into 3 groups, every group 20, i.e. model group:Any drug, sheet are not applied
Invention group example 1 drug 10mg/Kg, control drug group:Apply melbine (10mg/kg), method of application be it is oral, often
It sooner or later before meals half when take.It is detected after continuously taking 10 weeks;Blood glucose is monitored again after being discontinued 10 days.
Through detecting:Control drug group and medicine group fasting blood-glucose of the present invention, Urine proteins creatinine ratio, quantitative Urine proteins have
It is decreased obviously, drug of the present invention is significantly better than control drug group, and significant in efficacy, after stopping ten days, medicine group of the present invention does not have substantially
Rebound is occurred, referring specifically to following table.
Embodiment 5:Clinical case
General information:Outpatient service, III phase of diabetes B nephrosis belong to Qi deficiency blood stasis type patient totally 56, wherein male 30, female 26
Example, patient age 50-80 years old, fasting blood-glucose (FPG) and 2h-plasma glucose (2hPG) were sharply increased, and Urine proteins creatinine
Ratio is greater than 25mg/mmol, quantitative Urine proteins are greater than 150mg/24h.Take two courses for the treatment of of drug of the preparation of the embodiment of the present invention 1
Afterwards, above-mentioned biochemical indicator is detected.
It cures:FPG < 6.1mmol/L, 2h blood glucose (2hPG) < 8.0mmol/L, Urine proteins creatinine ratio is in 10~25mg/
Mmol, Urine proteins < 150mg is quantified for 24 hours;
Effectively:Fasting blood-glucose (FPG), 2h-plasma glucose (2hPG) make moderate progress, but not up to normal level, quantitative Urine proteins,
Urine proteins creatinine ratio reduces, but not up to normal level;
In vain:Fasting blood-glucose (FPG), postprandial 2h blood glucose (2hPG), quantitative Urine proteins, Urine proteins creatinine ratio nothing obviously change
Become.
Therapeutic effect:Healing 10, effective 45, invalid 1, total effective rate 98%.
Embodiment 6:Typical case
57 years old, diabetes B 3 years, there is pale white complexion in Mr. Lin, female, out of strength, and the few lazy speech of gas, dry is drunk more, insomnia and dreamful sleep, gas
It is short, it is dynamic then aggravate, vexed, blurred vision, edema of lower extremity.Tongue is dark red, and tongue fur is few, there is indentation, deep thready pulse.Fasting blood-glucose 8.8mmol/
L, 2h-plasma glucose 14.6mmol/L, quantitative Urine proteins 420mg/24h, Urine proteins creatinine ratio are 65mg/mmol, are diagnosed as sugar
Urinate sick III phase of nephrosis.The Chinese herbal compounds for giving embodiment 1, after taking 2 course for the treatment of, symptom mitigates, and continues to take 1 course for the treatment of Gong
Gu fasting blood-glucose is less than 7.0mmol/L, Urine proteins, Urine proteins creatinine ratio are normal.It is visited after half a year, blood glucose value is normal, kidney function
Normally.
Liu, male, 72 years old, 2 medical history 7 years type glycosuria phases, now has developed into III phase of diabetic nephropathy, existing dim complexion, weary
Power, dry are drunk more, and shortness of breath, hidrosis receive difference, blurred vision, double lower limb numbness oedema, and tongue is dark red.Indentations at the margin of the tongue, tongue fur is thin white,
Slow and sunken pulse.Fasting blood-glucose 12.8mmol/L, 2h-plasma glucose 18.0mmol/L, quantitative Urine proteins 380mg/24h, Urine proteins creatinine
Ratio is 52mg/mmol.Now take orally Glimepiride 1, QD, 1 TID of melbine.It gives and implements on the basis of original drug
The Chinese herbal compounds of example 1, after taking 2 course for the treatment of, symptom mitigates, and continues to take 1 course for the treatment of consolidation, fasting blood-glucose is less than 7mmol/
L, quantitative Urine proteins, Urine proteins creatinine are than normal.Multiple follow-up later, glucostasis in 7.0mmol/L hereinafter, renal function just
Often.
Claims (8)
1. a kind of Chinese medicine for treating diabetic nephropathy, it is characterized in that, it is mixed by the raw material of following parts by weight:Radix Astragali 20-
40 parts, 15-25 parts of Radix Angelicae Sinensis, 10-20 parts of Chinese yam, 20-40 parts of Radix Salviae Miltiorrhizae, 10-20 parts of Radix Codonopsis, 10-20 parts of radix paeoniae rubra, motherwort 10-20
Part, 20-40 parts of the fruit of Cherokee rose, 10-20 parts of radix rehmanniae recen, 8-12 parts of Fructus Corni, 10-20 parts of the fruit of glossy privet, 9-15 parts of safflower, Rhizoma Chuanxiong 10-
20 parts, 10-20 parts of Semen Cuscutae, 10-20 parts of radix achyranthis bidentatae, 9-15 parts of leech, 9-15 parts of pheretima, 2-4 parts of Radix Notoginseng, 6-12 parts of rheum officinale, Fu
10-20 parts of Siberian cocklebur, 20-40 parts of rhizoma alismatis, 20-40 parts of fleabane flower, 20-40 parts of gynostemma pentaphylla, 10-20 parts of tripterygium wilfordii, corn stigma 20-40
Part, 10-20 parts of Herba Euphorbiae Humifusae, 10-20 parts of turmeric, 20-40 parts of root of kirilow rhodiola.
2. the Chinese medicine for the treatment of diabetic nephropathy according to claim 1, it is characterized in that, it is mixed by the raw material of following parts by weight
Conjunction is made:30 parts of Radix Astragali, 20 parts of Radix Angelicae Sinensis, 15 parts of Chinese yam, 30 parts of Radix Salviae Miltiorrhizae, 15 parts of Radix Codonopsis, 15 parts of radix paeoniae rubra, 15 parts of motherwort, Jin Ying
Sub 30 parts, 15 parts of radix rehmanniae recen, 10 parts of Fructus Corni, 15 parts of the fruit of glossy privet, 12 parts of safflower, 15 parts of Rhizoma Chuanxiong, 15 parts of Semen Cuscutae, radix achyranthis bidentatae 15
Part, 12 parts of leech, 12 parts of pheretima, 3 parts of Radix Notoginseng, 9 parts of rheum officinale, 15 parts of Poria cocos, 30 parts of rhizoma alismatis, 30 parts of fleabane flower, 30 parts of gynostemma pentaphylla,
15 parts of tripterygium wilfordii, 30 parts of corn stigma, 15 parts of Herba Euphorbiae Humifusae, 15 parts of turmeric, 30 parts of root of kirilow rhodiola.
3. the Chinese medicine for the treatment of diabetic nephropathy according to claim 1 or 2, it is characterised in that:The Chinese medicine is capsule.
4. the preparation method of the Chinese medicine for the treatment of diabetic nephropathy according to claim 1, which is characterized in that including walking as follows
Suddenly:(1)Each bulk pharmaceutical chemicals are weighed respectively, it is spare;(2)Take Chinese yam, Radix Salviae Miltiorrhizae, Radix Codonopsis, radix paeoniae rubra, the fruit of Cherokee rose, safflower, Semen Cuscutae, leech,
Poria cocos, fleabane flower, Herba Euphorbiae Humifusae are uniformly mixed, and add water to cook twice, merge filtrate twice after filtrate is collected by filtration, are concentrated after cooling
Compound A is obtained at powder at medicinal extract, then dries pulverizing;(3)Take Radix Astragali, Radix Angelicae Sinensis, motherwort, radix rehmanniae recen, Fructus Corni, the fruit of glossy privet,
Rhizoma Chuanxiong, radix achyranthis bidentatae, pheretima, Radix Notoginseng, rheum officinale, rhizoma alismatis, gynostemma pentaphylla, tripterygium wilfordii, corn stigma, turmeric, root of kirilow rhodiola add ethyl alcohol to impregnate, and extract
Twice, combined extract filters, is condensed into medicinal extract, and crushed after being dried obtains compound B;(4)Compound A and compound B are mixed
It closes uniformly, capsule product is made in sterilization.
5. the preparation method of the Chinese medicine for the treatment of diabetic nephropathy according to claim 4, it is characterised in that:Step(2)In,
In decocting twice, for the first time plus the water of three times weight is boiled by intense fire, is then cooked by slow fire 1 hour, filtrate and filter residue is collected by filtration;
Into filter residue plus water regards no filter slag as criterion, and boils by intense fire, is then cooked by slow fire 30 minutes, filtrate is collected by filtration.
6. the preparation method of the Chinese medicine for the treatment of diabetic nephropathy according to claim 4, it is characterised in that:Step(2)With
(3)In, the density of medicinal extract is that 1.1-1.2g/mL is ground into powder, obtains compound A after drying at 80 DEG C.
7. the preparation method of the Chinese medicine for the treatment of diabetic nephropathy according to claim 4, it is characterised in that:Step(3)In,
Adding mass concentration is alcohol solution dipping 0.5-1.5 hours of 70%, is extracted twice, 1-2 hours each, combined extract.
8. the preparation method of the Chinese medicine for the treatment of diabetic nephropathy according to claim 4, it is characterised in that:Step(3)In,
The relative density of medicinal extract is 1.2.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811009506.3A CN108853433A (en) | 2018-08-31 | 2018-08-31 | A kind of Chinese medicine and preparation method thereof for treating diabetic nephropathy |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811009506.3A CN108853433A (en) | 2018-08-31 | 2018-08-31 | A kind of Chinese medicine and preparation method thereof for treating diabetic nephropathy |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108853433A true CN108853433A (en) | 2018-11-23 |
Family
ID=64323069
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811009506.3A Pending CN108853433A (en) | 2018-08-31 | 2018-08-31 | A kind of Chinese medicine and preparation method thereof for treating diabetic nephropathy |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108853433A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113041324A (en) * | 2021-04-27 | 2021-06-29 | 辽宁中医药大学 | Traditional Chinese medicine composition for treating qi deficiency and blood stasis type diabetic nephropathy and preparation method thereof |
CN113288998A (en) * | 2020-02-21 | 2021-08-24 | 防城港济仁堂中医门诊部 | Chinese medicinal formula for stabilizing blood sugar diseases and preparation scheme |
CN115887608A (en) * | 2022-11-30 | 2023-04-04 | 赵永芬 | A kind of traditional Chinese medicine composition and preparation for treating type II diabetes and its complications |
-
2018
- 2018-08-31 CN CN201811009506.3A patent/CN108853433A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113288998A (en) * | 2020-02-21 | 2021-08-24 | 防城港济仁堂中医门诊部 | Chinese medicinal formula for stabilizing blood sugar diseases and preparation scheme |
CN113041324A (en) * | 2021-04-27 | 2021-06-29 | 辽宁中医药大学 | Traditional Chinese medicine composition for treating qi deficiency and blood stasis type diabetic nephropathy and preparation method thereof |
CN115887608A (en) * | 2022-11-30 | 2023-04-04 | 赵永芬 | A kind of traditional Chinese medicine composition and preparation for treating type II diabetes and its complications |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103099959B (en) | Traditional Chinese medicine preparation for treating ulcerative colitis and preparation method thereof | |
CN103495040B (en) | Traditional Chinese medicine composition for treating reflux esophagitis and preparation method of granule formulation thereof | |
CN103990081A (en) | Traditional Chinese medicine composition and application thereof in preparation of medicine for treating infant jaundice | |
CN108853433A (en) | A kind of Chinese medicine and preparation method thereof for treating diabetic nephropathy | |
CN101757591B (en) | Traditional Chinese medicine composition for treating chronic colitis and protitis | |
CN102631595A (en) | Medicament for treating II-type diabetes mellitus and preparation method thereof | |
CN102657736B (en) | Medicament composition for treating rheumatoid arthritis and preparation method of medicament composition | |
CN102293928A (en) | Chinese medicinal composition for treating hyperuricemia and urarthritis, and preparation method and application thereof | |
CN104524214B (en) | Treat the Chinese medicine composition and its Chinese medicine preparation, preparation method and application of digestive tract ulcer | |
CN103211996B (en) | Preparation method of traditional Chinese medicine for treating diabetes mellitus | |
CN104983987A (en) | Traditional Chinese medicine colon dialyzate treating chronic renal failure | |
CN101890062A (en) | Application of nard pine and its extract in the preparation of medicine for treating gastric ulcer | |
CN104491101B (en) | Preparing method of traditional Chinese medicine preparation for treatment of chronic renal failure | |
CN104107352B (en) | A kind of blood pressure lowering Chinese herbal medicine and its instructions of taking | |
CN103585495B (en) | Capsule for treating diabetic kidney damage | |
CN103520684B (en) | Traditional Chinese medicine compound for reducing blood sugar | |
CN103230552B (en) | Traditional Chinese medicine for treating diabetes mellitus | |
CN108743885A (en) | A kind of Chinese medicine and preparation method thereof for treating Diabetic Macrovascular Complications | |
CN102274428B (en) | Pharmaceutical composition with effect on treating irritable bowel syndrome and preparation method and application thereof | |
CN105727089A (en) | Application of medicine composition containing folium artemisiae argyi to preparing medicine for treating irritable bowel syndrome | |
CN105055967A (en) | Compound health care product having auxiliary blood sugar reducing function and preparation method | |
CN104645144A (en) | Traditional Chinese medicine preparation for treating nephritis and preparation method of traditional Chinese medicine preparation | |
CN104524359B (en) | A kind of Chinese medicine composition, its preparation method and application | |
CN104474103A (en) | Natural plant hypoglycemic agent and preparation method thereof | |
CN104491102B (en) | Colon positioning traditional Chinese medicine preparation for treating chronic kidney failure |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181123 |
|
RJ01 | Rejection of invention patent application after publication |